🎂Today is a special day! We are celebrating our 6th anniversary! 🍾 We are so grateful for this incredible journey! We want to thank all our collaborators, partners, customers, but most of all we want to express our deepest gratitude to every member of the AlveoliX family. You are the ones who made all this...

🚨Breaking News! 🌞For those who missed it: AlveoliX was on SRF (at 14’40): here! 🚀 SRF recognized AlveoliX as a leading organs-on-chip company globally, highlighting our technology’s pivotal role in driving the step-by-step phase-out of animal testing in Switzerland. 📻 Don’t miss our segment on the 10vor10 program where Nina Hobi and Thomas Geiser highlight...

AlveoliX Joins PANC-CKI Consortium in Securing €4M Eurostars Grant for Pancreatic Cancer Research  Alveolix is pleased to be part of the PANC-CKI consortium, led by CasInvent Pharma, which has been awarded a €4M Eurostars grant. Competing with participants from 37 countries, the project achieved number one ranking in the Czech Republic, Switzerland, and France, with...

20240604_AlveoliX-EpiEndo-update